Nebenwirkungen · Fasturtec
Fasturtec 1.5 mg/ml powder and solvent for concentrate for solution for infusion. · Abschnitt 4.8 · PDF-Seite 4
HOS-091560 · Präparat HOS-084357
Adverse reactions possibly attributable to Fasturtec and reported in the clinical trials, are listed below, by system organ class and by frequency. Frequencies are defined using the following MedDRA convention as: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000); very rare (<1/10,000), not known (cannot be estimated from the
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-08-12T16:38:00Z · SHA-256 c445b3a957f181eb9a62824450927e9a73d8a29bfb733549c5a02959ba31763e · Passage df1dc6eaef2c555feead7eb6815a9dfae3e9242769ac3ddfe4d205c6bc8689e3 · Zeichen 786–1170 im Abschnitt